Genetic counselling implementation in dilated cardiomyopathy
Verdonschot, J. A. J., van Spaendonck-Zwarts, K. Y., Hellebrekers, D. M. E. I., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Garcia-Pavia, P., Haugaa, K. H., Jurcut, R., Kuchynka, P., Lopes, L. R., Mazzanti, A., Metra, M., Monserrat, L., Kaski, J. P., Pantazis, A., Prasad, S. K., Rosano, G., Seferovic, P. M., Sheppard, M. N., Sinagra, G., Tome Esteban, M. T., Heymans, S. R. B., van Tintelen, J. P.
Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities
Evans, P. C., Vilahur, G., Kleinbongard, P., Osto, E., Remme, C. A., Madonna, R., Aksentijevic, D., Sourij, H., Davidson, S. M., Santovito, D., Gindlhuber, J., Weber, C., Linke, W. A., Lutgens, E., Bertrand, L., Dawson, D., Bäck, M., Norata, G. D., Wojta, J., Perrino, C.
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer’s disease
Wischik, C. M., Stefanacci, R., Bentham, P., Gauthier, S., Zetterberg, H., Wilcock, G. K., Froelich, L., Burns, A., MacSweeney, E., Ballard, C., Yu, J., Choon, T. S., Asvatourian, V., Muehlemann, N., Priel, J., Kook, K., Sullivan, T., Downie, D., Miller, S., Pringle, C., Storey, J. M. D., Baddeley, T., Harrington, C. R., Penny, L. K., Arastoo, M., Staff, R., Sandu, A., Shiells, H., Lo, S., Nazlee, N., Evans, E., Hull, C., Schelter, B. O.
The Journal of Prevention of Alzheimer's Disease, vol. 13, no. 3, 100480
Baseline characteristics of patients recruited to the mannitol for cerebral oedema after acute intracerebral haemorrhage (MACE-ICH) trial
Krishnan, K., Grace, E., Woodhouse, L., Roffe, C., Dawson, J., England, T. J., Hewson, D. W., Dineen, R. A., Law, Z. K., Pszczolkowski, S., Wells, K., Buck, A., Craig, J., Havard, D., Macleod, M. J., Werring, D. J., Doubal, F. N., Sprigg, N., Bath, P. M.
Clinical Neurology and Neurosurgery, vol. 264, 109342
Timing matters: early administration of a high-affinity antibody targeting the tau repeat domain prevents aggregation in a mouse tauopathy model
Porter, A.
Alzheimer's Research & Therapy
Contributions to Journals: Articles
Long-read sequencing reveals increased isoform diversity in key transcription factor effectors of intercellular signalling at the invertebrate-vertebrate transition
Torres-Aguila, N. P., Salonna, M., Shimeld, S. M., Hoppler, S., Ferrier, D. E.